Group A, C Meningococcal Polysaccharide-Conjugate Vaccine

Group A, C Meningococcal Polysaccharide-Conjugate Vaccine
Product Description

MeningACon is the first approved product in China,more than 36 million doses has been used.

Chongqing Zhifei Biological Products Co., Ltd.

  • CN
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Manufacturer/Innovator
Specifications
  • Selling Points
    Quality Service
  • Supplied from
    China

Chongqing Zhifei Biological Products Co., Ltd.

  • CN
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Manufacturer/Innovator

More Products from Chongqing Zhifei Biological Products Co., Ltd. (4)

  • Recombinant COVID-19 Vaccine(CHO Cell)

    Product Recombinant COVID-19 Vaccine(CHO Cell)

    Zifivax is the first approved Recombinant COVID vaccine, there are more than 300million doses used worldwide.
  • Recombinant Mycobacterium Tuberculosis Fusion Protein

    Product Recombinant Mycobacterium Tuberculosis Fusion Protein

    C-TST is a new diagnose method to detect Mtb infectionfor,which uses antigen-specific (ESAT6 & CFP10) immune response, same with the principle of action used in IGRAs.(1)Suitable for Large Scale LTBI Screening; 
    (2)Non Cross-React with BCG Vaccine; 
    (3)WHO Guideline Recommended;  q...
  • semaglutide

    Product semaglutide

    we can supply the semaglutide API with a good price and good quality,we are also open for the cooperation model.
  • Meningococcal Polysaccharide Vaccine

    Product Meningococcal Polysaccharide Vaccine

    Chongqing zhifei biological products co., ltd offers a wide range of products which includes meningococcal polysaccharide vaccine. Function and use: it can be used to prevent epidemic cerebrospinal meningitis caused by meningococcus group a, c, y, and w135 infection. Contact us for more information.

Chongqing Zhifei Biological Products Co., Ltd. resources (1)